CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

por Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Córdoba, Alicia, Vicente-García, Francisco, Blanco-Luquin, Idoia, De La Cruz, Susana, Aramendia, Ana, Guerrero-Setas, David
Publicado 2017

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer

por Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Blanco-Luquin, Idoia, Córdoba, Alicia, Vicente-García, Francisco, Pérez-Janices, Noemí, Escors, David, Megías, Diego, López-Serra, Paula, Esteller, Manel, Illarramendi, José Juan, Guerrero-Setas, David
Publicado 2017

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis

por Perez-Janices, Noemi, Blanco-Luquin, Idoia, Torrea, Natalia, Liechtenstein, Therese, Escors, David, Cordoba, Alicia, Vicente-Garcia, Francisco, Jauregui, Isabel, De La Cruz, Susana, Illarramendi, José Juan, Coca, Valle, Berdasco, Maria, Kochan, Grazyna, Ibañez, Berta, Lera, José Miguel, Guerrero-Setas, David
Publicado 2015